Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect?
Open Access
- 1 January 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 108 (1) , 191-193
- https://doi.org/10.1046/j.1365-2141.2000.01813.x
Abstract
Deep vein thrombosis (DVT) is associated with coagulation abnormalities, but evidence of excess platelet activity is scant. Soluble P‐selectin is a marker of platelet activity, with high levels being found in patients with thrombotic disease. We measured soluble P‐selectin by enzyme‐linked immunosorbent assay (ELISA) in plasma from 89 patients with objectively confirmed DVT and in 126 healthy age‐ and sex‐matched control subjects, and found higher levels in the patients (P = 0.011). Taking the risk of DVT with a level of soluble P‐selectin < 238 ng/ml to be 1, the relative risk of DVT with a soluble P‐selectin level >238 ng/ml was 2.1 (95% CI 1.2–3.6). These high levels may be a reflection of a generalized hypercoagulable state that, with factors such as the presence of persistent thrombin generation, could be responsible for excess platelet activation.Keywords
This publication has 14 references indexed in Scilit:
- Soluble P-Selectin Is Released from Activated Platelets in vivo during HemodialysisNephron, 1998
- The Origin of P-selectin as a Circulating Plasma ProteinThrombosis and Haemostasis, 1997
- Thrombosis in the Young: Epidemiology and Risk Factors. A Focus on Venous ThrombosisThrombosis and Haemostasis, 1997
- THE INFLUENCE OF SMOKING ON SOLUBLE ADHESION MOLECULES AND ENDOTHELIAL CELL MARKERSThrombosis Research, 1997
- Hypothesis: is soluble P-selectin a new marker of platelet activation?Atherosclerosis, 1997
- The Leiden Thrombophilia Study (LETS)Thrombosis and Haemostasis, 1997
- Elevated Circulating P-Selectin in Insulin Dependent Diabetes MellitusThrombosis and Haemostasis, 1996
- Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) [see comments]Blood, 1995
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992
- Diagnostic Value of Fibrinopeptide A and Beta‐Thromboglobulin in Acute Deep Venous Thrombosis and Pulmonary EmbolismActa Medica Scandinavica, 1982